An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 55 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Male and non pregnant female
18-55 years old
Sufficient abdominal fat for injections
Signed informed consent
Known hypersensitivity to study drugs
Treatment with an investigational agent within 30 days before first dose